About the Authors

Alan Engelman
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, Massachusetts, United States of America

Peter Cherepanov
Division of Medicine, Imperial College London, St. Mary's Campus, London, United Kingdom

Corresponding Authors

Competing Interests

The authors have declared that no competing interests exist.